Franck Verrecchia

7.9k total citations · 3 hit papers
99 papers, 6.2k citations indexed

About

Franck Verrecchia is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Franck Verrecchia has authored 99 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 17 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Franck Verrecchia's work include TGF-β signaling in diseases (26 papers), Connexins and lens biology (12 papers) and Cell Adhesion Molecules Research (12 papers). Franck Verrecchia is often cited by papers focused on TGF-β signaling in diseases (26 papers), Connexins and lens biology (12 papers) and Cell Adhesion Molecules Research (12 papers). Franck Verrecchia collaborates with scholars based in France, United States and United Kingdom. Franck Verrecchia's co-authors include Alain Mauviel, Françoise Rédiní, Mon‐Li Chu, Dominique Farge, Isabelle Corre, Valérie Trichet, Vincent Crenn, Sylviane Dennler, Azeddine Atfi and Jocelyne André and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Franck Verrecchia

97 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach

2001 562 citations Franck Verrecchia, Alain Mauviel et al. Journal of Biological Chemistry profile →
Transforming Growth Factor-β Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation

2002 553 citations Franck Verrecchia, Alain Mauviel Journal of Investigative Dermatology profile →
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

2020 334 citations Franck Verrecchia, Françoise Rédiní et al. Cells profile →

Peers

Countries citing papers authored by Franck Verrecchia

Since Specialization

Citations

This map shows the geographic impact of Franck Verrecchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Verrecchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Verrecchia more than expected).

Fields of papers citing papers by Franck Verrecchia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Verrecchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Verrecchia. The network helps show where Franck Verrecchia may publish in the future.

Co-authorship network of co-authors of Franck Verrecchia

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Verrecchia. A scholar is included among the top collaborators of Franck Verrecchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Verrecchia. Franck Verrecchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience 2024 ·Pediatric Blood & Cancer ·Paul Bastard, Nathalie Cozic, Régis Brion, Nathalie Gaspar, Sophie Piperno‐Neumann, (unknown), (unknown), (unknown), Françoise Rédiní, Antonin Marchais, (unknown), (unknown), Valérie Laurence, Charlotte Rigaud, Rachid Abbas, Franck Verrecchia, Laurence Brugières, Véronique Minard‐Colin	1
2	Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells 2023 ·Environmental Health Perspectives ·(unknown), (unknown), Céline Charrier, Bénédicte Brounais-Le Royer, Pierre‐François Cartron, Franck Verrecchia, Marc Baud’huin, François Lamoureux, (unknown), Benjamin Ory	4
3	Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619 2021 ·Cells ·(unknown), (unknown), (unknown), Jérôme Amiaud, Mélanie Legrand, (unknown), Régis Brion, Sarah Morice, (unknown), (unknown), Bénédicte Brounais-Le Royer, François Lamoureux, Benjamin Ory, Françoise Rédiní, Franck Verrecchia	25
4	The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth 2020 ·Cancers ·Sarah Morice, (unknown), Régis Brion, (unknown), (unknown), (unknown), Bénédicte Brounais-Le Royer, Benjamin Ory, Françoise Rédiní, Franck Verrecchia	30
5	Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment 2018 ·Frontiers in Oncology ·Franck Verrecchia, Françoise Rédiní	101
6	ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis 2016 ·Cancer Research ·Lidia Rodriguez Calleja, Camille Jacques, François Lamoureux, Marc Baud’huin, Marta Tellez Gabriel, Thibaut Quillard, Debashish Sahay, Pierre Perrot, Jérôme Amiaud, Céline Charrier, Régis Brion, Fernando Lecanda, Franck Verrecchia, Dominique Heymann, Leif W. Ellisen, Benjamin Ory	43
7	Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression 2015 ·Clinical Cancer Research ·Benjamin Ory, Marc Baud’huin, Franck Verrecchia, Bénédicte Brounais-Le Royer, Thibaut Quillard, Jérôme Amiaud, Séverine Battaglia, Dominique Heymann, Françoise Rédiní, François Lamoureux	28
8	Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma 2014 ·Clinical Cancer Research ·Audrey Lamora, Julie Talbot, Gwenola Bougras, Jérôme Amiaud, Marion Leduc, Julie Chesneau, Julien Taurelle, Verena Stresing, Marie‐Cécile Le Deley, Marie‐Françoise Heymann, Dominique Heymann, Françoise Rédiní, Franck Verrecchia	90
9	Communication intercellulaire et remodelage osseux 2012 ·Biologie Aujourd hui ·Julie Talbot, Franck Verrecchia	2
10	Therapeutic Approach of Primary Bone Tumours by Bisphosphonates 2010 ·Current Pharmaceutical Design ·Gatien Moriceau, Benjamin Ory, (unknown), Franck Verrecchia, F. Gouin, Frédéric Blanchard, Françoise Rédiní, Dominique Heymann	30
11	Cloning of the Human GLI2 Promoter 2009 ·Journal of Biological Chemistry ·Sylviane Dennler, Jocelyne André, Franck Verrecchia, Alain Mauviel	111
12	Existe-t-il une action antifibrosante spécifique des immunosuppresseurs utilisés pour traiter la sclérodermie systémique ? 2009 ·La Revue de Médecine Interne ·Franck Verrecchia, Laurence Michel, (unknown), (unknown), David Launay, Dominique Farge	1
13	c‐Fos accelerates hepatocyte conversion to a fibroblastoid phenotype through ERK‐mediated upregulation of paxillin‐Serine178 phosphorylation 2008 ·Molecular Carcinogenesis ·(unknown), Jocelyne André, Agnès Legrand, Niclas Setterblad, Alain Mauviel, Franck Verrecchia, Fanny Daniel, Dominique Bernuau	6
14	Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis 2007 ·Annals of the Rheumatic Diseases ·Jérôme Larghero, Dominique Farge, Alessandra Braccini, Séverine Lecourt, Arnaud Scherberich, Eléna Foïs, Franck Verrecchia, (unknown), Éliane Gluckman, Alan Tyndall, Chiara Bocelli‐Tyndall	94
15	[Cellular and molecular mechanisms of fibrosis]. 2006 ·PubMed ·(unknown), Franck Verrecchia, (unknown), Patrick Bruneval	3
16	Transforming growth factor-β signaling through the Smad proteins: Role in systemic sclerosis 2006 ·Autoimmunity Reviews ·Franck Verrecchia, Alain Mauviel, Dominique Farge	102
17	Fluorescence Recovery After Photobleaching 2003 ·Humana Press eBooks ·J. Délèze, (unknown), (unknown), Franck Verrecchia, Jean‐Claude Hervé	17
18	Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling 2002 ·Oncogene ·Olivier Ferrigno, François Lallemand, Franck Verrecchia, Sébastien L’Hoste, Jacques Camonis, Azeddine Atfi, Alain Mauviel	175
19	Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue Fibrosis 2001 ·Journal of Investigative Dermatology ·Franck Verrecchia, Alain Mauviel, Jérôme Rossert	104
20	Reversible inhibition of gap junctional communication by tamoxifen in cultured cardiac myocytes 1997 ·Pflügers Archiv - European Journal of Physiology ·Franck Verrecchia, (unknown)	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact